back to overview


MTIP Healthcare Clinic 2019

April 18, 2019 + Jessica Di Palo
5 Min read

Basel, April 9th, 2019 MTIP presented its journey in the healthtech sector with its insights on the current industry developments, its great portfolio and an exciting outlook of the future with MTIP Fund ll.

The MTIP Healthcare Clinic 2019 took place in the Victoria Hotel Basel. The guests were welcomed by MTIP’s chairman Dr. Felix Grisard and in the following overview, Dr. Christoph Kausch enlightened the invited audience about MTIP’s main differentiators. MTIP is one of the leading European investors in Healthtech and connects the traditional healthcare sector with new technologies, emerging from the IT sector. By being one of the least digitalized sectors and decreasing productivity over the last couple of years, healthcare strives for improvements. Digitalization in healthcare is just emerging and offers enormous opportunities which are mainly uncorrelated to the traditional financial markets and therefore offer a highly attractive risk-reward profile for investors.

Based on this, Dr. Claudia Colciago presented MTIP’s view on future developments in the healthcare sector and emphasized the importance of investing in companies with a strong and sustainable growth trajectory. Artificial intelligence will have a major impact on healthcare, but AI technology can only be leveraged if a robust framework to collect, structure, and share data is established beforehand. In the future, Digital Health companies will help in delivering affordable and efficient care to patients all around the globe.

Speaking about excellent examples of affordable and efficient care, MTIP’s portfolio was presented by the investment partner David Germonpré. Last year’s new investments Quanta Dialysis, Lumeon and Cynerio were presented by their respective management team. Thanks to their expertise, the audience had a deep dive into several hot topics around chronic diseases, decentralized care, optimization of treatment delivery and cybersecurity.

MTIP was able to establish this great portfolio in under three years and more is coming. The future steps and the key terms of the MTIP Fund II concluded the presentations. The audience was fascinated by MTIP’s development and engaged in insightful discussion during the Apéro riche, enjoying a stunning view over Basel.

Share the Article


Diversity, Equity, and Inclusion: The 3 Key Drivers for Success

We have talked with Caroline Noublanche, CEO of our portfolio company Apricity, about her company’s DEI efforts.


Growth Capital Decisions – An Interview with our Co-Founder & Managing Partner Dr. Christoph Kausch

Growth Capital Decisions


Rahel Hafner Receives Certificate in ESG Investing by CFA Institute

Rahel Hafner Receives Certificate in ESG Investing


What Makes a Great Founder/Investor Relationship?

Interview with the CEO and Co-Founder Kai Eberhardt of our portfolio company Oviva


MTIP’s HealthCare Clinic 2022

This year's HealthCare Clinic was held under the motto: "Surfing the Healthtech Waves of Change".


Christoph Kausch selected by Real Deals as most influential for 2022

Christoph Kausch named by Real Deals most influential for 2022


MTIP leads €17 million financing round in virtual fertility clinic Apricity

New MTIP investment


MTIP leads the €20 million growth financing round in LynxCare

Largest capital round ever in digital health in Belgium


Pioneering the use of machine learning algorithms to turbo-charge drug development

Intelligencia revolutionizes drug development


The psychology of decision making

What makes a good investor?


Revolutionizing medical triage with artificial intelligence

Mediktor's solution for medical triage


MTIP Closes Second Healthtech Growth Fund Above Target With $250M of Commitments

MTIP Fund II is closed!


Cynerio Now! – A new IoT cybersecurity solution for small hospitals and clinics

Cynerio's new product Cynerio Now!


MTIP invests in Mediktor

New investment in Mediktor


SFDR Art. 8 or Art. 9? What’s the difference?

SFDR: getting the terminology right


MTIP participates in Oviva’s new $80m Series C funding

Oviva raises $80 million financing round


MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence

MTIP's new investment in Intelligencia


Private Equity 101: Part one – Glossary

Are you new to the healthtech space?


Leading brands revolutionize care journeys with Lumeon

How Lumeon orchestrates care journey


Trialbee – our hero in patient matching and recruiting for clinical trials

Trialbee - patient matching and recruiting

news blog

Digital healthcare: patient-first?

Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital

SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?

New SFDR obligations


MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation

First Closing of Fund II


How to pitch to a healthtech Investor

Blog Pitching


MTIP invests in Koa Health to make mental health treatment more accessible

New investment in Koa Health